 |
|
Hepatitis C virus-induced hepatocellular carcinoma
Nicolas Goossens, Yujin Hoshida
Clin Mol Hepatol. 2015;21(2):105-114. Published online 2015 Jun 26 DOI: https://doi.org/10.3350/cmh.2015.21.2.105
|
|
Citations to this article as recorded by
 Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma
Daniel Q. Huang, Joseph K. Hoang, Rubayet Kamal, Pei-Chien Tsai, Hidenori Toyoda, Ming-Lun Yeh, Satoshi Yasuda, Jennifer Leong, Mayumi Maeda, Chung-Feng Huang, Dae Won Jun, Masatoshi Ishigami, Yasuhito Tanaka, Haruki Uojima, Eiichi Ogawa, Hiroshi Abe, Yao
Journal of Clinical Oncology.2024; 42(7): 790. CrossRef Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma
Jun Il Kim, Jayoun Lee, Gi Hong Choi, Min Woo Lee, Dong Ah Park, Jeong-Ju Yoo
Digestive Diseases and Sciences.2024; 69(3): 1055. CrossRef Assessment of gankyrin mRNA expression in tissue and liquid biopsy as a sensitive biomarker for hepatocellular carcinoma
Levan Gogichaishvili, Gia Lobzhanidze, Hans Schlit, Zanda Bedinashvili, Lali Sharvadze, Nana Goishvili, Mikheil Jangavadze
World Academy of Sciences Journal.2024;[Epub] CrossRef Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
Yuanjie Liu, Elena S. Kim, Haitao Guo
Journal of Medical Virology.2024;[Epub] CrossRef Combination treatment of hepatitis C virus-associated hepatocellular carcinoma by simultaneously blocking genes in multiple organelles via functionally engineered graphene oxide
Seongchan Kim, Ji-Seon Lee, Hyojin Lee
Chemical Engineering Journal.2023; 452: 139279. CrossRef Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017
Irina Tskhomelidze, Shaun Shadaker, Tinatin Kuchuloria, Lia Gvinjilia, Maia Butsashvili, Muazzam Nasrullah, Tamar Gabunia, Amiran Gamkrelidze, Vladimer Getia, Lali Sharvadze, Tengiz Tsertsvadze, Jaba Zarqua, Shota Tsanava, Senad Handanagic, Paige A. Armst
Liver International.2023; 43(3): 558. CrossRef Hepatitis C—Route of Asymptomatic to Symptomatic Switch in Raising Hepatocarcinogenesis: Revisiting Nobel Prize 2020 in Physiology and Medicine
Rajdeep Shaw, Bhramar Dutta, Dipanjana Ghosh, Rajib Bandopadhyay
National Academy Science Letters.2023; 46(1): 51. CrossRef Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful
Walaa Abdelhamed, Mohamed El‐Kassas
Journal of Viral Hepatitis.2023; 30(2): 148. CrossRef Therapeutic options in hepatocellular carcinoma: a comprehensive review
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar
Clinical and Experimental Medicine.2023; 23(6): 1901. CrossRef Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
I. A. Goncharova, A. A. Zarubin, N. P. Babushkina, I. A. Koroleva, M. S. Nazarenko
Vavilov Journal of Genetics and Breeding.2023; 27(1): 72. CrossRef The role of viruses in cancer development versus cancer therapy: An oncological perspective
Hossein Javid, Alireza Sharbaf Mashhad, Shaghayegh Yazdani, Mahsa Akbari Oryani, Sanaz Akbari, Nastaran Rezagholinejad, Mahboubeh Tajaldini, Mehdi Karimi‐Shahri
Cancer Medicine.2023; 12(10): 11127. CrossRef Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines.2023; 11(4): 1166. CrossRef Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology.2023; 24(7): 711. CrossRef The Immunohistochemical Staining of Vimentin and E-Cadherin in Bladder Cancer Patients Infected with Hepatitis C Virus
May K. Ismael, Yasir B. Qaddoori, Mustafa N. Shaban, Bahaa Abdullah Laftaah AL-Rubaii
Journal of Pure and Applied Microbiology.2023; 17(2): 1009. CrossRef Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma
Chun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, Nicole Hyacinth Calpatura Orpilla, Mai Chan Lau, Chun Jye Lim, Xinru Lim, Justina Nadia Li Wen Lee, Jeffrey Chun Tatt Lim, Sherlly Lim, Qing Cheng, Han Chong Toh, Su Pin Choo, Suat Ying Lee, J
Frontiers in Immunology.2023;[Epub] CrossRef The potential role of the microbiota in prostate cancer pathogenesis and treatment
Nicolò Pernigoni, Christina Guo, Lewis Gallagher, Wei Yuan, Manuel Colucci, Martina Troiani, Lei Liu, Luisa Maraccani, Ilaria Guccini, Denis Migliorini, Johann de Bono, Andrea Alimonti
Nature Reviews Urology.2023; 20(12): 706. CrossRef Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancer
Korri E El-Khobar, Enoch Tay, Eve Diefenbach, Brian S Gloss, Jacob George, Mark W Douglas
Life Science Alliance.2023; 6(11): e202201630. CrossRef Human tumor viruses: induction of three-dimensional alterations in the host genome structure
Janos Minarovits
Frontiers in Microbiology.2023;[Epub] CrossRef Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents
Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief, Hussein H. Aly
Frontiers in Virology.2023;[Epub] CrossRef Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma
Joanna J. Song, Andrea Chobrutskiy, Boris I. Chobrutskiy, Konrad J. Cios, Taha I. Huda, Rachel A. Eakins, Michael J. Diaz, George Blanck
Viral Immunology.2023; 36(10): 669. CrossRef An Insight into Hepatitis C Virus: In Search of Promising Drug Targets
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee
Current Drug Targets.2023; 24(14): 1127. CrossRef The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation
Ishfaq Hassan Mir, K. C. Jyothi, Chinnasamy Thirunavukkarasu
Journal of Cellular Biochemistry.2022; 123(10): 1607. CrossRef Heparanase-1 is upregulated by hepatitis C virus and favors its replication
Christophe Gallard, Nadjet Lebsir, Hira Khursheed, Emma Reungoat, Marie-Laure Plissonnier, Jennifer Bré, Maud Michelet, Yasmina Chouik, Fabien Zoulim, Eve-Isabelle Pécheur, Birke Bartosch, Boyan Grigorov
Journal of Hepatology.2022; 77(1): 29. CrossRef Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut
Cancers.2022; 14(11): 2700. CrossRef Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line
Muhammad Atif, Muhammad Abdul Mustaan, Sadia Falak, Abdul Ghaffar, Bushra Munir
Saudi Journal of Biological Sciences.2022; 29(8): 103332. CrossRef Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Ch
The Lancet Gastroenterology & Hepatology.2022; 7(11): 1036. CrossRef Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development
Aqsa Ikram, Bisma Rauff, Badr Alzahrani, Faryal Mehwish Awan, Ayesha Obaid, Anam Naz, Salik Javed Kakar, Hussnain Ahmed Janjua
Scientific Reports.2022;[Epub] CrossRef Manipulation of Interleukin-6 (IL-6) and Transforming Growth Factor Beta-1(TGFβ-1) towards viral induced liver cancer pathogenesis
Yasmin Badshah, Maria Shabbir, Khushbukhat Khan, Maha Fatima, Iqra Majoka, Laiba Aslam, Huda Munawar, Srinivas Mummidi
PLOS ONE.2022; 17(10): e0275834. CrossRef The role of infections in the causation of cancer in Kenya
Vivian C. Tuei, Geoffrey K. Maiyoh, Fidelis T. Ndombera
Cancer Causes & Control.2022; 33(12): 1391. CrossRef Lipid profile changes after direct acting antiviral treatment in different genotypes of chronic hepatitis C virus‐infected patients
Cheng‐Heng Lin, Jyh‐Jou Chen, Pei‐Lun Lee, Hung‐Da Tung, Chun‐Ta Cheng, Hsu‐Ju Kao, Yu‐Hsun Wu, Mai‐Gio Pang, Tang‐Wei Chuang
Advances in Digestive Medicine.2021; 8(3): 139. CrossRef The Inflammasome Components NLRP3 and ASC Act in Concert with IRGM To Rearrange the Golgi Apparatus during Hepatitis C Virus Infection
Coralie F. Daussy, Sarah C. Monard, Coralie Guy, Sara Muñoz-González, Maxime Chazal, Marit W. Anthonsen, Nolwenn Jouvenet, Thomas Henry, Marlène Dreux, Eliane F. Meurs, Marianne Doré Hansen, J.-H. James Ou
Journal of Virology.2021;[Epub] CrossRef Stimulation of hepatocarcinogenesis by activated cholangiocytes via Il17a/f1 pathway in kras transgenic zebrafish model
Mohamed Helal, Chuan Yan, Zhiyuan Gong
Scientific Reports.2021;[Epub] CrossRef Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection
Mohammed El-Mowafy, Abdelaziz Elgaml, Mohamed El-Mesery, Salma Sultan, Tamer A. E. Ahmed, Ahmed I. Gomaa, Mahmoud Aly, Walid Mottawea
Biology.2021; 10(1): 55. CrossRef The Pivotal Role of Viruses in the Pathogeny of Chronic Lymphocytic Leukemia: Monoclonal (Type 1) IgG K Cryoglobulinemia and Chronic Lymphocytic Leukemia Diagnosis in the Course of a Human Metapneumovirus Infection
Jérémy Barben, Alain Putot, Anca-Maria Mihai, Jérémie Vovelle, Patrick Manckoundia
Viruses.2021; 13(1): 115. CrossRef Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognos- tic factor in hepatitis C virus-related hepatocellular carcinoma
Ching-Chih Lin, Ta-Wei Liu, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang, Chia-Yen Dai, Ming-Lung Yu
Clinical and Molecular Hepatology.2021; 27(2): 313. CrossRef The role of IL-4 gene polymorphism in HCV-related hepatocellular carcinoma in Egyptian patients
Mohy-Eldin Abd-Elfattah, Mary Naguib, Mohammed Elkheer, Eman Abdelsameea, Ali Nada
Egyptian Liver Journal.2021;[Epub] CrossRef HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly
Stefania Brozzetti, Marsia Tancredi, Simone Bini, Chiara De Lucia, Jessica Antimi, Chiara D’Alterio, Giuseppe Maria De Sanctis, Caterina Furlan, Vittoria Carolina Malpassuti, Pierleone Lucatelli, Michele Di Martino, Mario Bezzi, Antonio Ciardi, Rosa Maria
Cancers.2021; 13(12): 3025. CrossRef High Seroprevalence of Hepatitis C Virus Antibody in Breast Cancer Patients in Egypt
Osama Hussein, Engy Mohamed El-Ghitany, Mawadda Omran, Ghadier Matariek, Esraa Ahmed Elbadaly, Rana Hamdy, Amira Gamal, Mai Mohamed Zayed, Ahmed Nasr, Omar Hamdy, Mohamed Elbasiony, Khaled Abdelwahab
Breast Cancer: Basic and Clinical Research.2021; 15: 117822342110024. CrossRef Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, Daniel Todt, Eike Steinmann
Cancers.2021; 13(22): 5867. CrossRef Epidemiology of viral hepatitis C: Road to elimination in Japan
Ko Ko, Tomoyuki Akita, Masahiro Satake, Junko Tanaka
Global Health & Medicine.2021; 3(5): 262. CrossRef The expression of microRNA-331-3p and microRNA-23b3 in Egyptian patients with early-stage hepatocellular carcinoma in hepatitis C-related liver cirrhosis
Reham A. Aboelwafa, Walid Ismail Ellakany, Marwa A. Gamaleldin, Marwa A. Saad
Egyptian Liver Journal.2021;[Epub] CrossRef Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
Alejandro Olivares-Hernández, Luis Figuero-Pérez, José Pablo Miramontes-González, Álvaro López-Gutiérrez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Emilio Fonseca-Sánchez
Life.2021; 11(12): 1400. CrossRef Discovery of Novel Sequences in 1,000 Swedish Genomes
Jesper Eisfeldt, Gustaf Mårtensson, Adam Ameur, Daniel Nilsson, Anna Lindstrand, Evelyne Heyer
Molecular Biology and Evolution.2020; 37(1): 18. CrossRef Mechanistic study of interaction between IL-22 and HCV core protein in the development of hepatocellular carcinoma among liver transplant recipients
Saleha Resham, Muhammad Saalim, Sobia Manzoor, Hassam Ahmad, Tariq Ali Bangash, Amer Latif, Shahla Jaleel
Microbial Pathogenesis.2020; 142: 104071. CrossRef Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis
Xiang Cui, Xiaoyan Jiang, Chunshan Wei, Yufeng Xing, Guangdong Tong
Environmental Toxicology and Pharmacology.2020; 78: 103397. CrossRef A regression-based model for predicting the best mode of treatment for Egyptian liver cancer patients
Esraa Hamdi Abdelaziz, Khaled ElBahnasy, Sanaa Moharram Kamal, Rasha Ismail
Network Modeling Analysis in Health Informatics and Bioinformatics.2020;[Epub] CrossRef Reversal of T Cell Exhaustion in Chronic HCV Infection
Sylwia Osuch, Karin J. Metzner, Kamila Caraballo Cortés
Viruses.2020; 12(8): 799. CrossRef Investigating circulatory microRNA expression profiles in Egyptian patients infected with hepatitis C virus mediated hepatic disorders
Abdullah Ahmed Gibriel, Amany Mohamed Al-Anany, Mohamed Ali Ezz Al-Arab, Hassan Mohamed Elsaid Azzazy
Meta Gene.2020; 26: 100792. CrossRef Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
Harry Ho Man Ng, Ren Yuan Lee, Siting Goh, Isabel Shu Ying Tay, Xinru Lim, Bernett Lee, Valerie Chew, Huihua Li, Benedict Tan, Sherlly Lim, Jeffrey Chun Tatt Lim, Bijin Au, Josh Jie Hua Loh, Sahil Saraf, John Edward Connolly, Tracy Loh, Wei Qiang Leow, Jo
Journal for ImmunoTherapy of Cancer.2020; 8(2): e000987. CrossRef Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors
A. V. Zamaraev, B. Zhivotovsky, G. S. Kopeina
Biochemistry (Moscow).2020; 85(10): 1191. CrossRef Long Non-Coding HULC and miRNA-372 as Diagnostic Biomarkers in Hepatocellular Carcinoma patients
Olfat Shaker, Hala Mahfouz, Ahmad Salama, Engy Medhat
Reports of Biochemistry and Molecular Biology.2020; 9(2): 230. CrossRef Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar
Frontiers in Oncology.2020;[Epub] CrossRef Direct-Acting Antiviral Agents Reduce the Risk of Malignant Transformation of Hepatobiliary Phase-Hypointense Nodule without Arterial Phase Hyperenhancement to Hepatocellular Carcinoma on Gd-EOB-DPTA-Enhanced Imaging in the Hepatitis C Virus-Infected Live
Yoshiaki Shimizu, Kuniaki Arai, Taro Yamashita, Tatsuya Yamashita, Tetsuro Shimakami, Kazunori Kawaguchi, Kazuya Kitamura, Yoshio Sakai, Eishiro Mizukoshi, Masao Honda, Azusa Kitao, Kazuto Kozaka, Satoshi Kobayashi, Shuichi Kaneko
Liver Cancer.2020; 9(3): 261. CrossRef Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma
Daniela Manuc, Carmen Monica Preda, Irina Sandra, Cristian Baicus, Razvan Cerban, Ileana Constantinescu, Andrei Ovidiu Olteanu, Cosmin Alexandru Ciora, Teodora Manuc, Daniela Elena Chiriac, Andreea Elena Chifulescu, Mircea Diculescu, Cristian Tieranu, Luc
Journal of Medicine and Life.2020; 13(1): 68. CrossRef Hepatitis C virus genotype 3 was associated with the development of hepatocellular carcinoma in Korea
Sang Soo Lee, Cha Young Kim, Bo Ra Kim, Ra Ri Cha, Wan Soo Kim, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok‐Jae Lee
Journal of Viral Hepatitis.2019; 26(4): 459. CrossRef Hepatocellular Carcinoma: Etiology and Current and Future Drugs
Aastha Jindal, Anusha Thadi, Kunwar Shailubhai
Journal of Clinical and Experimental Hepatology.2019; 9(2): 221. CrossRef Repression of MicroRNA‐30e by Hepatitis C Virus Enhances Fatty Acid Synthesis
Reina Sasaki, Subhayan Sur, Qi Cheng, Robert Steele, Ratna B. Ray
Hepatology Communications.2019; 3(7): 943. CrossRef Long Noncoding RNA HCP5, a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations
Jerzy K. Kulski
Cells.2019; 8(5): 480. CrossRef Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice
Katja Straub, Peri Husen, Hideo A. Baba, Martin Trippler, Heiner Wedemeyer, Kerstin Herzer
Cancer Medicine.2019; 8(8): 3793. CrossRef Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention
Uyen Ngoc Mui, Christopher T. Haley, Ramya Vangipuram, Stephen K. Tyring
Journal of the American Academy of Dermatology.2019; 81(1): 23. CrossRef Chronic Hepatitis C: Conspectus of immunological events in the course of fibrosis evolution
Dejan Baskic, Vuk Vukovic, Suzana Popovic, Danijela Jovanovic, Slobodanka Mitrovic, Predrag Djurdjevic, Dusko Avramovic, Aleksandra Arsovic, Dragic Bankovic, Jelena Cukic, Zeljko Mijailovic, Esaki M. Shankar
PLOS ONE.2019; 14(7): e0219508. CrossRef
The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)‐
α via
signal transducer and activator of transcription (STAT)3 and extracellular signal‐regulated kinase (ERK)–
Orla Convery, Siobhan Gargan, Michelle Kickham, Martina Schroder, Cliona O'Farrelly, Nigel J. Stevenson
The FASEB Journal.2019; 33(8): 8732. CrossRef A model-based framework for chronic hepatitis C prevalence estimation
Abdullah Hamadeh, Zeny Feng, Murray Krahn, William W. L. Wong, Isabelle Chemin
PLOS ONE.2019; 14(11): e0225366. CrossRef Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors
Young-Joo Jin, Seyoun Byun, Seonggyun Han, John Chamberlin, Dongwook Kim, Min Jung Kim, Younghee Lee
BMC Medical Genomics.2019;[Epub] CrossRef Sustained virological response by direct‑acting antivirals reduces the recurrence risk of hepatitis C‑related hepatocellular carcinoma after curative treatment
Kenji Imai, Koji Takai, Tatsunori Hanai, Atsushi Suetsugu, Makoto Shiraki, Masahito Shimizu
Molecular and Clinical Oncology.2019;[Epub] CrossRef Interleukin-6-572 promoter gene polymorphism and its association with chronic hepatitis C-induced hepatocellular carcinoma: an Egyptian study
Bothina Madkour, Alaa Gad, Mona S. Hamdy, Nariman Zahran, Mohamed Aboul-Ezz
Comparative Clinical Pathology.2018; 27(1): 161. CrossRef Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma
Naglaa F. Alsalawy, Rania K. Darwish, Manal M. Kamal, Ahmed E. ElTaweel, Hend I. Shousha, Tamer M. Elbaz
Journal of Medical Virology.2018; 90(3): 490. CrossRef Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
Amna Subhan Butt, Fatima Sharif, Shahab Abid
World Journal of Hepatology.2018; 10(2): 267. CrossRef miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma
Chaoxing Li, Valentin Dinu
Journal of Biomedical Informatics.2018; 81: 31. CrossRef Pathways of topological rank analysis (PoTRA): a novel method to detect pathways involved in hepatocellular carcinoma
Chaoxing Li, Li Liu, Valentin Dinu
PeerJ.2018; 6: e4571. CrossRef Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals
Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano,
Clinical and Molecular Hepatology.2018; 24(2): 151. CrossRef Simultaneous Determination of Elbasvir and Grazoprevir in Their Pharmaceutical Preparation Using High-Performance Liquid Chromatographic Method
Khalid A M Attia, Nasr M El-Abasawi, Ahmed El-Olemy, Ahmed H Abdelazim, Mohammed El-Dosoky
Journal of Chromatographic Science.2018; 56(8): 731. CrossRef Association between proton pump inhibitors and the risk of hepatocellular carcinoma
Y.‐H. J. Shao, T.‐S. Chan, K. Tsai, S.‐Y. Wu
Alimentary Pharmacology & Therapeutics.2018; 48(4): 460. CrossRef High prevalence of a variety of autoantibodies in a population of hepatitis C virus‐infected individuals
Luz Marina Navarta, Carlos Alberto Espul, Nelson Acosta‐Rivero
APMIS.2018; 126(6): 515. CrossRef Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct‐acting antivirals
Ayumi Sugiura, Satoru Joshita, Takeji Umemura, Tomoo Yamazaki, Naoyuki Fujimori, Takefumi Kimura, Akihiro Matsumoto, Koji Igarashi, Yoko Usami, Shuichi Wada, Hiromitsu Mori, Soichiro Shibata, Kaname Yoshizawa, Susumu Morita, Kiyoshi Furuta, Atsushi Kamijo
Journal of Viral Hepatitis.2018; 25(12): 1462. CrossRef ‘It’s been a long haul, a big haul, but we’ve made it’: hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysis
Anna Krzeczkowska, Paul Flowers, Zoe Chouliara, Peter Hayes, Adele Dickson
Health Psychology Open.2018; 5(2): 205510291879267. CrossRef Molecular mechanisms of viral oncogenesis in humans
Nathan A. Krump, Jianxin You
Nature Reviews Microbiology.2018; 16(11): 684. CrossRef Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma
Marwa Zahra, Hassan Azzazy, Ahmed Moustafa
Scientific Reports.2018;[Epub] CrossRef Impact of the Uridine–Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients—A Pilot Study
Arida Buivydiene, Valentina Liakina, Elena Kashuba, Jolita Norkuniene, Skirmante Jokubauskiene, Egle Gineikiene, Jonas Valantinas
Medicina.2018; 54(5): 67. CrossRef Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis
Maria I. Poole, Inmaculada Sorribes, Harsh Vardhan Jain
Mathematical Biosciences.2018; 306: 186. CrossRef HEPATOCELLULAR CARCINOMA IN THE COHORT OF VIETNAMESE PATIENTS WITH CHRONIC HEPATITIS C
N. Н. Chung, D. A. Lioznov, S. L. Nikolaenko
HIV Infection and Immunosuppressive Disorders.2018; 10(3): 108. CrossRef Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes
Hairong Zhu, Jian Wu, Xizhong Shen
Scandinavian Journal of Gastroenterology.2017; 52(2): 209. CrossRef Hepatocellular carcinoma
David J. Pinato, Alessia Dalla Pria, Rohini Sharma, Mark Bower
AIDS.2017; 31(5): 603. CrossRef Ultrastructural and biochemical basis for hepatitis C virus morphogenesis
Viviana Falcón, Nelson Acosta-Rivero, Sirenia González, Santiago Dueñas-Carrera, Gillian Martinez-Donato, Ivon Menéndez, Rocio Garateix, José A. Silva, Emilio Acosta, Juan Kourı
Virus Genes.2017; 53(2): 151. CrossRef Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection
Kentaro Matsuura, Hiromi Sawai, Kazuho Ikeo, Shintaro Ogawa, Etsuko Iio, Masanori Isogawa, Noritomo Shimada, Atsumasa Komori, Hidenori Toyoda, Takashi Kumada, Tadashi Namisaki, Hitoshi Yoshiji, Naoya Sakamoto, Mina Nakagawa, Yasuhiro Asahina, Masayuki Kur
Gastroenterology.2017; 152(6): 1383. CrossRef Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies
Sayed Shahabuddin Hoseini, Nai-Kong V. Cheung
Cancer Letters.2017; 399: 44. CrossRef The Path to Cancer and Back
Jose D. Debes, Robert J. de Knegt, Andre Boonstra
Transplantation.2017; 101(5): 910. CrossRef Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances
Guoxiu Yan, Xuefu Wang, Cheng Sun, Xiaodong Zheng, Haiming Wei, Zhigang Tian, Rui Sun
Scientific Reports.2017;[Epub] CrossRef Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
Chang Woo Shim, Joong-Won Park, So Hee Kim, Jin Sook Kim, Bo Hyun Kim, Sung Hoon Kim, Eun Kyung Hong
Therapeutic Advances in Gastroenterology.2017; 10(7): 529. CrossRef Quantitative proteome analysis of plasma microparticles for the characterization of HCV‐induced hepatic cirrhosis and hepatocellular carcinoma
Raghda Saad Zaghloul Taleb, Pacint Moez, Doreen Younan, Martin Eisenacher, Matthias Tenbusch, Barbara Sitek, Thilo Bracht
PROTEOMICS – Clinical Applications.2017;[Epub] CrossRef Mechanisms involved in liver damage resolution after hepatitis C virus clearance
T.B. Salas-Villalobos, S.A. Lozano-Sepúlveda, A.R. Rincón-Sánchez, M. Govea-Salas, A.M. Rivas-Estilla
Medicina Universitaria.2017; 19(75): 100. CrossRef Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
Kashif Asghar, Asim Farooq, Bilal Zulfiqar, Muhammad Usman Rashid
World Journal of Gastroenterology.2017; 23(13): 2286. CrossRef Synthesis and anti-HCV activity of a series of β- d -2′-deoxy-2′-dibromo nucleosides and their corresponding phosphoramidate prodrugs
Zhe Chen, Bryan D. Cox, Ethel C. Garnier-Amblard, Tamara R. McBrayer, Steven J. Coats, Raymond F. Schinazi, Franck Amblard
Bioorganic & Medicinal Chemistry Letters.2017; 27(23): 5296. CrossRef Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad
World Journal of Hepatology.2017; 9(36): 1305. CrossRef Viral Oncology: Molecular Biology and Pathogenesis
Uyen Mui, Christopher Haley, Stephen Tyring
Journal of Clinical Medicine.2017; 6(12): 111. CrossRef How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study
Vahdat Poortahmasebi, Mansour Poorebrahim, Saeideh Najafi, Seyed Mohammad Jazayeri, Seyed Moayed Alavian, Seyed Shahriar Arab, Saeid Ghavami, Seyed Ehsan Alavian, Adel Rezaei Moghadam, Mehdi Amiri
Hepatitis Monthly.2016;[Epub] CrossRef Malignancies and thalassemia: a review of the literature
Sara Zanella, Maria Chiara Garani, Caterina Borgna‐Pignatti
Annals of the New York Academy of Sciences.2016; 1368(1): 140. CrossRef Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti, Federica Buonfiglioli, Alessandra Scuteri, Cristina Crespi, Luigi Bolondi, Paolo Caraceni, Francesco Giuseppe Foschi, Marco Lenzi, Giuseppe Mazzella, Gabriella Verucchi, Pietro Andreone, Stefano Brillanti
Journal of Hepatology.2016; 65(4): 727. CrossRef Anti-hepatocellular carcinoma activity and mechanism of chemopreventive compounds: ursolic acid derivatives
Qiuxia Huang, Hongfei Chen, Yuyan Ren, Zhe Wang, Peiyu Zeng, Xuan Li, Juan Wang, Xing Zheng
Pharmaceutical Biology.2016; 54(12): 3189. CrossRef Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis
Miriam Canavese, Danushka Wijesundara, Guy J Maddern, Branka Grubor‐Bauk, Ehud Hauben
Clinical & Translational Immunology.2016;[Epub] CrossRef The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?
José R. Blanco, Antonio Rivero-Juárez
Expert Review of Anti-infective Therapy.2016; 14(11): 993. CrossRef Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma
Simonetta Bandiera, C Billie Bian, Yujin Hoshida, Thomas F Baumert, Mirjam B Zeisel
Current Opinion in Virology.2016; 20: 99. CrossRef Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients
Marwa K. Ibrahim, Hosny Salama, Mohamad Abd El Rahman, Reham M. Dawood, Noha G. Bader El Din, Heba F. Salem, Mohamed E.A. Abdelrahim, Dalia Omran, Moataza H. Omran, Khaled Helmi El-Wakeel, Tawfeek H. Abdelhafez, Ahmed Khedr, Mostafa K. El Awady
Journal of Interferon & Cytokine Research.2016; 36(12): 698. CrossRef The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?
Alessio Strazzulla, Rosa Maria Rita Iemmolo, Ennio Carbone, Maria Concetta Postorino, Maria Mazzitelli, Mario De Santis, Fabrizio Di Benedetto, Costanza Maria Cristiani, Chiara Costa, Vincenzo Pisani, Carlo Torti
Hepatitis Monthly.2016;[Epub] CrossRef Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets
Gabor Szebeni, Csaba Vizler, Lajos Nagy, Klara Kitajka, Laszlo Puskas
International Journal of Molecular Sciences.2016; 17(11): 1958. CrossRef Effects of interactions between environmental factors andKIF1Bgenetic variants on the risk of hepatocellular carcinoma in a Chinese cohort
Jun-Hu Chen, Yan-Yan Wang, Wei-Biao Lv, Yu Gan, Wei Chang, Na-Na Tian, Xiao-Hui Huang, Li Liu, Xin-Fa Yu, Si-Dong Chen
World Journal of Gastroenterology.2016; 22(16): 4183. CrossRef Tumour-inducing viruses
RA Weiss
British Journal of Hospital Medicine.2016; 77(Sup10): 565. CrossRef Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
Pil Sung, Eui-Cheol Shin, Seung Yoon
International Journal of Molecular Sciences.2015; 16(10): 23683. CrossRef
|